Separate names with a comma.
SBUX doing poorly this year, actually negative YTD. Also lost the $100 handle. What's the matter here, "coffee causes cancer" story going to come...
When the prior year was negative and the current year is up >10% (but <38%) in the first half (like now), the rest of year has gained at least 6%...
Small caps (IWM) are keeping the market up.
Jobless claims tomorrow morning, and also GDP estimates. Those could turn the market back down.
I'll wait for the Coke-ketchup. I always see people playing pickleball at the park, bringing their own net. One of the TV news shows tried to...
Bounce today but QQQ is still leading to the downside. QQQ/SPY did not break downtrend even with today's bounce. [IMG] VIX got really low...
Specifically big cap tech. The equal-weighted QQQ (QQQE) was marginally up. The equal-weighted SPY (RSP) was +0.61%.
Netflix announced a new viewership metric, # of views. It's real simple, they take the old metric (# of hours) and divide by the length of the...
Consumers not dead yet.
I was not expecting AI to bounce back so fast, but then I was not expecting SPX to hit 4400 in 2 weeks. AI making a new high today, so of course...
I would not expand the charging network myself if I was Tesla. If the network gets expanded, Tesla would be wise to make their new partners pay...
Agreed. I'm starting to like this stock. Hated it when their only job was to beat AMD/NVDA processors. But they're going to be making chips for...
SPX on a 5-day winning streak. Got to keep riding this momentum for now. This week is OpX week, and usually the week after is down. [IMG]
The JETS etf is up every day this month, outperforming even semiconductors this month.
/NQ going through 15k
/NQ hit 14,999.50
Be careful. The VIX is up +7% today. And the new VIX1D is +38%. CPI comes out tomorrow, and PPI on Wednesday.
Note that the former "Weight Watchers" now trades as WW, and WTW was taken by Willis Towers (which used to be traded under WLTW). So the first...
This drug got approved on Friday. It is going to be marketd as Leqembi. This time the panel said patients should be able to make their own...
